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A B S T R A C T
Background
Art therapy is defined by the British Association of Art Therapists as: “a form of psychotherapy that uses art media as its primary mode
of communication. Clients who are referred to an art therapist need not have experience or skill in art. The art therapist is not primarily
concerned with making an aesthetic or diagnostic assessment of the client’s image. The overall aim of its practitioners is to enable a
client to change and grow on a personal level through the use of art materials in a safe and facilitating environment”. Historically,
drawings and paintings have been recognised as a useful part of therapeutic processes within psychiatric and psychological specialties,
and this has been acknowledged within medical and neurology-based disciplines.
Arts-based therapies are generally considered as interventions managing manifestations of dementia, as they may help to slow cognitive
deterioration, address symptoms related to psychosocially challenging behaviours and improve quality of life.
Objectives
To review the effects of art therapy as an adjunctive treatment for dementia compared with standard care and other non-pharmacological
interventions.
Search methods
We identified trials from ALOIS - the Cochrane Dementia and Cognitive Improvement Group’s Specialised Register - on 12May 2014,
20 March 2015, 15 January 2016, 4 November 2016, and 4 October 2017. We also handsearched the grey literature and contacted
specialists in the field and authors of relevant reviews or studies to enquire about other sources of relevant information.
Selection criteria
All randomised controlled trials examining art therapy as an intervention for dementia.
Data collection and analysis
Two review authors independently extracted data. We examined scales measuring cognition, affect and emotional well-being, social
functioning, behaviour and quality of life.
Main results
We found two studies that met the inclusion criteria, incorporating data on a total of 60 participants (from 88 randomised), in
experimental groups (n = 29) and active control groups (n = 31). One study compared group art therapy with simple calculation
activities over 12 weeks. The other study compared group art therapy with recreational activities over 40 weeks. It was not possible to
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pool the data for analysis from the included studies, due to heterogeneity in terms of differences in the interventions, control treatments
and choice of outcome measures.
In both studies there were no clear changes reported between the intervention group and the control group in the important outcome
measures. According to GRADE ratings, we judged the quality of evidence for these outcome measures to be ’very low’.
Authors’ conclusions
There is insufficient evidence about the efficacy of art therapy for people with dementia. More adequately-powered and high-quality
studies using relevant outcome measures are needed.
P L A I N L A N G U A G E S U M M A R Y
Inconclusive findings on the effects of art therapy for people with dementia
Title
Art therapy for people with dementia
Background
Dementia is a common condition that affects people’s memory. It can also affect people’s thinking, emotions and behaviour. Dementia
has a major impact on health and society across the world. Some types of treatment other than medication may help people with
dementia.
Art therapy is a type of psychological therapy, which means a treatment for problems of the mind and behaviour. Art can be used as
a way to express and communicate thoughts and feelings. The aim of art therapists is to work with patients in ways that help them
change and ’grow’ on a personal level. This is done by using art materials in a safe environment that allows this process.
Study Characteristics
We looked at research trials of people with dementia doing art therapy, compared with usual care and other activities. We looked at
effects of art therapy on memory and thinking, emotions, well-being, social behaviour and quality of life. We also looked at negative
effects and costs of art therapy. We found two research studies with a total of 88 older people taking part. There were results for 60
people. One study compared groups doing art therapy or simple calculation activities over 12 weeks. The other study compared groups
doing art therapy or recreational activities over 40 weeks. The evidence is current to October 2017.
Key Results
These two studies found no clear changes in memory or most other outcomes looked at when comparing art therapy to other activities.
Quality of the Evidence
The studies were limited by many factors that reduced the quality of findings - considered ’very low’ with well-known methods for
evaluating this. Each study used different types of art therapy. This made it difficult to look at all the results together. One study had a
high rate of people not completing the research trial. The studies included small numbers of people, which makes it difficult to be sure
how accurate the findings are. This also makes it difficult to know if the effects will be the same in more people. Art therapy is difficult
to test for its effects.
More research is needed on this topic. There is not enough information from research trials about the effects of art therapy for people
with dementia. This review suggests ways to do this.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Art therapy compared with active control group activity for people with dementia
Patient or population: people with dementia
Setting: outpat ient clinic or day-care and resident ial sett ings
Intervention: art therapy
Comparison: act ive control (calculat ion or recreat ional act ivity)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with active control
(calculation or recre-
ational activity)
Risk with art therapy
Change in MMSE
follow-up: 12 weeks
The mean change in
MMSE was +2.1
The mean change in
MMSE was -0.2
- 39
(1 RCT)
⊕©©©
VERY LOW 12
-
Change in Apathy Scale
follow-up: 12 weeks
The mean change in Ap-
athy Scale was -1.1
The mean change in Ap-
athy Scale was -3.2
- 39
(1 RCT)
⊕©©©
VERY LOW a,b
-
Change in CSDD
follow-up: 40 weeks
The mean change in
CSDD was -0.17
The mean change in
CSDD was +5.89
- 21
(1 RCT)
⊕©©©
VERY LOW a,b,c,
-
Change in MCS-8
follow-up: 12 weeks
The mean change in
MCS-8 was -1.9
The mean change in
MCS-8 was +2.1
- 39
(1 RCT)
⊕©©©
VERY LOW a,b
-
Adverse ef fects
follow-up: mean 26
weeks
Not est imable The mean adverse ef -
fects in the intervent ion
groups was undef ined
- 60
(2 RCTs)
⊕©©©
VERY LOW a,b,c
-
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aRisk of bias - downgraded for high risks of performance bias and attrit ion bias.There were unclear risks of select ion bias and
detect ion bias due to insuf f icient information about blinding and allocat ion process.
bInconsistency - downgraded for methodological heterogeneity and a high degree of inconsistency in the ef fect on outcomes
between studies.
cImprecision - small sample size with results reported for endpoint group sizes of 9 and 12, due to high attrit ion rates.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Description of the condition
Dementia is a progressive clinical syndrome characterised by
widespread cognitive impairment. Dementia has a number of dif-
ferent causes and the term encompasses multiple degenerative
brain disorders that affect memory, thinking, behaviour, emotion
and performance in activities of daily living (Alzheimer’s Disease
International 2010).
The global prevalence of dementia in 2015 was estimated at 46.8
million, with numbers almost doubling every 20 years, and the
estimated prevalence rising to 131.5 million by 2050 (Alzheimer’s
Disease International 2015). Dementia continues to have a sig-
nificant socio-economic impact on health and social care systems
(Alzheimer’s Disease International 2015).
Alzheimer’s Disease International has advocated more commis-
sioning and funding of research (Alzheimer’sDisease International
2011), including researching the efficacy of pharmacological and
non-pharmacological interventions specifically for the early stages
of dementia. There is a large body of ongoing research into phar-
macological treatments but, traditionally, less has been directed
towards non-pharmacological therapies (Van der Steen 2017). In-
terventions may be broadly categorised as those aimed at modify-
ing disease processes, and targeting the causes and managing man-
ifestations of the disease. Arts-based therapies are generally consid-
ered to fall within the last category, as they may help to slow cog-
nitive deterioration, address symptoms related to psychosocially
challenging behaviours and improve quality of life.
Description of the intervention
Art therapy is defined by the British Association of Art Therapists
as: “a form of psychotherapy that uses art media as its primary
mode of communication. Clients who are referred to an art ther-
apist need not have experience or skill in art. The art therapist is
not primarily concerned with making an aesthetic or diagnostic
assessment of the client’s image. The overall aim of its practition-
ers is to enable a client to change and grow on a personal level
through the use of art materials in a safe and facilitating environ-
ment” (BAAT 2013; Ruddy 2005). Our review focuses on studies
of art therapy and does not include studies of other arts therapies
(dance-movement therapy, drama therapy or music therapy).
Historically, drawings and paintings have been recognised as a use-
ful part of therapeutic processes within psychiatric and psycho-
logical specialties (BAAT 2013), and this has been acknowledged
within medical and neurology-based scientific audiences (Burton
2009), as well as through media coverage in wider societal con-
texts (BAAT 2013). In the UK, employment of art therapists by
the National Health Service (NHS) began in the 1940s, and art
therapy is now statutorily regulated in the UK (BAAT 2013). It
is a legal requirement in the UK that in order to practise profes-
sionally, art therapists must graduate from a recognised course and
gain registration from the Health and Care Professions Council
(BAAT 2013).
How the intervention might work
There is ongoing discussion about the theoretical base of art ther-
apy. This is complex and may be considered in terms of “dynamic,
humanistic, systemic and social understandings of art, therapy, and
people” (Huss 2009). Within the literature some authors make
a key distinction between art as a treatment (focusing on clini-
cal outcomes) and as an activity (focusing on the creative pro-
cess itself ), whilst others consider art therapy as a creative therapy
that offers a holistic approach to a person’s condition and illness
(Beard 2012a). It is believed that the therapeutic effects relate to
the art-making process as well as the interactions comprising the
therapist-patient relationship (Edwards 2004). Existing theoreti-
cal models may therefore focus on the process and context of art
making, or on the use of art as an analytical and projective tool
(Huss 2009; Schaverien 1992). A multi-layered model has also
been suggested, integrating the different theoretical conceptuali-
sations (Huss 2009).
Art therapy involves creative activity and art-making processes tar-
geting cognitive, motor, emotional and interpersonal skills. Art
therapy also serves as a non-verbal expressive medium, thereby
offering insights into the patient’s ‘inner world’ through a three-
way process between the patient, the therapist and art materials
(object or image) (BAAT 2013). Experts have suggested potential
physiological (neurological) and psychological mechanistic expla-
nations for the effects of visual art interventions. These hypothe-
ses are often inter-related and considered in conjunction with one
another.
The general literature cites studies showing that art therapy has
measurable subjective benefits in facilitating functioning through
reminiscence and rediscovery of obscured abilities; improving
quality of life through affirming the individual’s sense of self
and promoting psychological well-being; and helping reduce per-
ceived problem behaviours associated with dementia (Van der
Steen 2017; Waller 2002), as well as indicating the potential for
positive objective biomedical treatment outcomes (Alzheimer’s
Disease International 2011; Beard 2012a). More recently, authors
of a study seeking to develop theoretical understanding considered
how art gallery-based programmes involving processes of view-
ing and making art within the physical and social context of the
gallery, might impact people with dementia and their caregivers
(Camic 2016), discussed the emergence of four components they
proposed as critical factors in creating positive emotional and re-
lational effects for participants: intellectual stimulation, the per-
ceived importance of which was considered to be in keeping with
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the increasing use of cognitive stimulation therapy groups (Spector
2003); the setting of a valued place or environment, away from
daily activities or associations with illness; social relationships and
interaction including peer support and respite for caregivers; and
changed perceptions of dementia, afforded by the shared experi-
ence of self-reported positive affect and social inclusion associated
with the intervention processes (Camic 2016).
Art therapy involves sensory and intellectual stimulation, and the
latter has been considered important in terms of interest, com-
petency and engagement of participants (Camic 2016). There is
some emerging evidence for the effects of cognitive interventions
such as cognitive stimulation on cognitive function, and hypothe-
ses about the potential effects of cognitive interventions on neu-
ronal processes underlying cognitive impairment, in healthy el-
derly individuals and in those with mild cognitive impairment
and early Alzheimer’s disease (Huntley 2015; Bahar-Fuchs 2013;
Belleville 2011; Martin 2011).
A recent neuroimaging study exploring the effects of visual art
on the functional neuroanatomy of the brain in post-retirement
adults reported that making visual art improved effective interac-
tion between the regions of the brain network being investigated
and that these improvements were associated with better scores
for psychological resilience, demonstrating links between the ba-
sic cognitive neuroscience finding to a clinically-relevant finding
with potential therapeutic implications (Bolwerk 2014). Further
research is required to examinewhether improvements in impaired
connectivity in functional brain networks are associated with pos-
itive effects on measures of cognition, affect and emotional well-
being, behaviour and social functioning in clinical disease states.
The neurological basis of creativity and its role in dementia re-
mains to be elucidated, both in terms of the creative experience of
patients and the effects of creative activity on the brain. It has been
suggested that there may be links between altered creativity and
some psychiatric and neurological diseases, with efforts to explain
these in terms of neuropsychology and anatomy, although the
nature of these associations remains unclear (Flaherty 2011). Al-
though cognitive function progressively declines during the course
of the disease, studies have found that some individuals even with
advanced dementia may be able to complete self-portraits when
requested (Beard 2012a). Cerebral damage may be reflected in im-
paired artistic ability, as is often the case in Alzheimer’s disease de-
mentia. However, some patients with brain disease display emerg-
ing, enduring or enhanced artistry (Flaherty 2011; Schott 2012).
This has been highlighted in the temporal variant of fronto-tem-
poral dementia, a relatively rare form of dementia where there is
pathological involvement of the anterior temporal lobes whilst the
dorsolateral frontal cortex is spared, resulting in adversely-affected
language and social skills, but sparing of visual skills, with the ac-
quisition of new artistic skills observed in some patients (Miller
1998). However any inferred implications for treatments such as
art therapy are limited by insufficient research evidence (Flaherty
2011).
Why it is important to do this review
During the last 50 years case studies and qualitative research have
assessed the use of art therapy in dementia (BAAT 2013; Burton
2009); however, our review aims to summarise higher-quality evi-
dence of its effects from randomised controlled trials. A systematic
review of evidence for the effects of art therapy in the care of people
with dementia is required to inform future clinical applications
and research directions regarding this form of therapy.
The benefits of pharmacological treatments are limited in the long-
term management of many features of dementia (Van der Steen
2017).Non-pharmacological interventions are considered to be an
important adjunctive approach. Non-pharmacological therapies
for dementia that have been suggested previously include cognitive
stimulation and reality orientation, reminiscence therapy, psycho-
logical treatments, including cognitive behavioural therapy, psy-
chosocial interventions, physical exercise, caregiver-focused inter-
ventions, drama therapy and music therapy (Alzheimer’s Disease
International 2011; Beard 2012a; Van der Steen 2017).
The advantages of non-pharmacological interventions include the
lack of typical drug-associated adverse effects and potential cost-
saving benefits, including delayed institutionalisation and en-
hanced quality of life (Alzheimer’s Disease International 2011).
These interventions may serve as an appropriate adjunct to phar-
macological therapies, or may offer a suitable alternative for
the mainstay of therapy in those individuals who do not meet
evidence-based criteria for acetylcholinesterase inhibitor drugs
(Alzheimer’s Disease International 2011).
In a broader sense, this review of art therapy contributes to the
existing body of evidence for non-pharmacological group-based
activities and psychological therapies for people with dementia.
It is possible there may be some overlap in non-pharmacological
group and activity-based interventions involving similar compo-
nents to those hypothesised to be key to the mechanisms of action
of art-based therapies, including the group setting and social inter-
action, engaging in enjoyable activities, and providing stimulation
for cognitive processes (BAAT 2013; Bolwerk 2014; Camic 2016;
Woods 2012). This review of the efficacy of art therapy for people
with dementia is important to add to the existing evidence base for
cognitive and psychological interventions as well as group-based
creative activities for people with dementia.
BAAT identifies art therapy as a form of psychotherapy and Na-
tional Institute for Health and Care Excellence (NICE) guidelines
currently recommend psychological interventions for people with
dementia with co-morbid emotional disorders such as depression
or anxiety or both, including a range of tailored interventions
such as reminiscence therapy andmultisensory stimulation (NICE
2006). NICE guidelines recommend therapeutic use of creative
arts based activities tailored to individual preferences, skills and
abilities, including music and dancing, for people with dementia
with co-morbid agitation (NICE 2006).
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O B J E C T I V E S
To review the effects of art therapy as an adjunctive treatment for
dementia compared with standard care and other non-pharmaco-
logical interventions.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) in which art therapy was
used as an intervention for people with any form of dementia,
compared with standard care or other psychosocial interventions
for dementia.
Types of participants
We included studies in which participants had a formal (clinician-
confirmed) diagnosis of any form of dementia. We included par-
ticipants resident in the community or in any form of institutional
care and with all severities of dementia.
Types of interventions
The experimental intervention of art therapy, administered to a
group or individually. We considered a minimum of five sessions
to constitute a therapeutic intervention. We used the aforemen-
tioned British Association of Art Therapists’ definition of art ther-
apy as a gold standard for inclusion (BAAT 2013). We did not in-
clude studies that used multi-modal interventions in which it was
not possible to distinguish the specific effects of the art therapy
component.
Acceptable control interventions included no treatment, usual
care, or any other form of non-pharmacological intervention for
dementia.
Types of outcome measures
Primary outcomes
• Cognition: includes the following cognitive domains:
attention/orientation, memory, fluency, language skills (speech
content and fluency) and visuospatial perception
• Affect and emotional well-being (where ’affect’ is
considered the fluctuating changes in emotion or feelings)
• Social functioning
• Behaviour
• Adverse effects
We accepted all validated cognitive, behavioural and psychological
scales, and global impression measures reported by authors of the
primary studies and deemed appropriate by the review authors.
Secondary outcomes
• Death
• Quality of life
• Economic outcomes
Search methods for identification of studies
Electronic searches
We searched theCochraneDementia andCognitive Improvement
Group’s Specialised Register, on 12 May 2014, 20 March 2015,
15 January 2016, 4 November 2016, and 4 October 2017. The
search terms we used included: art, artistic, artist, artwork, draw,
drawing, paint, painting, sketch, sketching, doodle.
ALOIS is maintained by the Cochrane Dementia and Cognitive
Improvement Group’s Information Specialists and contains de-
mentia and cognitive-improvement studies identified from:
1. Monthly searches of a number of major healthcare
databases: MEDLINE, Embase, CINAHL, PsycINFO and
LILACS
2. Monthly searches of a number of trial registers:
metaRegister of Controlled Trials; Umin Japan Trial Register;
WHO portal (which covers ClinicalTrials.gov; ISRCTN;
Chinese Clinical Trials Register; German Clinical Trials Register;
Iranian Registry of Clinical Trials; and the Netherlands National
Trials Register, plus others
3. Quarterly searches of the Cochrane Library’s Central
Register of Controlled trials (CENTRAL)
4. Six-monthly searches of a number of grey literature sources:
ISI Web of Knowledge Conference Proceedings; Index to
Theses; Australasian Digital Theses
We ran additional separate searches in many of the above sources
to ensure that we retrieved the most up-to-date results. The search
strategy used for the retrieval of reports of trials from MEDLINE
(via the Ovid SP platform) can be seen in Appendix 1.
Searching other resources
1. Handsearching
We handsearched the grey literature, such as conference proceed-
ings, and searched the reference lists of all the included studies
as well as other potentially relevant trials identified through the
above search strategy. We did not apply any language restrictions.
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2. Personal contact
We contacted authors of relevant reviews or studies to enquire
about other sources of relevant information. We had already con-
tacted Val Huet, the Chief Executive Officer for the British As-
sociation of Art Therapists as part of the review proposal process.
We contacted Professor Diane Waller, a co-author of a relevant
study.
Data collection and analysis
Selection of studies
Two review authors independently assessed all the studies iden-
tified through the search strategy for eligibility, by checking the
title or abstract or both. If there was any doubt about an article’s
relevance, we assessed the full-text article. Where necessary, we
resolved any disagreement through discussion or, if required, we
consulted a third party. Where necessary, we contacted authors of
the original reports to provide further information.
Data extraction and management
For eligible studies, two review authors extracted and cross-
checked outcome data independently. We used a proforma that
we had designed for data collection.
Assessment of risk of bias in included studies
We used the Cochrane ’Risk of bias’ tool, a domain-based evalua-
tion (Higgins 2011). Two review authors independently assessed
risks of bias for included studies using the criteria outlined in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011).We assessed the following elements of each included study:
sequence generation, allocation concealment, blinding of partici-
pants, personnel and outcome assessors, incomplete outcome data,
selective reporting bias and other potential sources and risks of
bias (Higgins 2011).
Measures of treatment effect
Dichotomous data
We reported data forMCS-8 (a quality-of-life measure) as an odds
ratio (OR).
Continuous data
Most outcome measures were continuous data reported as the
mean change in each group where the studies published their re-
sults as mean values for each group at baseline and post-interven-
tion, allowing the absolute difference between themean value to be
calculated as an estimate of the amount by which the intervention
or control changed the outcome on average. For most outcome
measures we did not report the standard deviation of the changes,
confidence intervals and P values for differences between inter-
vention and control groups. We reported data for Mini-Mental
State Examination (MMSE: a cognitive-impairment measure) in
terms of P values for differences between intervention and control
groups.
Dealing with missing data
For included studies, we noted levels of attrition. We discuss the
potential impact of missing data on the findings of the review.
R E S U L T S
Description of studies
See: Characteristics of included studies and Characteristics of
excluded studies
We identified 922 results after de-duplication for assessment. Two
studies met the criteria for inclusion. The studies varied in par-
ticipant characteristics, length of individual art therapy sessions,
number of sessions and duration, nature of the activities defined
as art therapy, the nature of the control condition, and outcome
measures. We consider these factors below in turn.
(1) Study settings
Hattori 2011: Hospital (outpatient basis - psychiatry or memory
clinic) in Obu, Aichi, Japan.
Rusted 2006: Day centre or residential facility in East Sussex, UK.
(2) Participant characteristics
Hattori 2011: The intervention group was composed of 20 par-
ticipants (11 women) with a mean age of 75.3 ± 5.3 years and
baseline MMSE 24.6 ± 3.4. The control group was composed of
19 participants (10 women) with an average age of 73.3 ± 6.3 years
and baseline MMSE 22.3 ± 2.7. Four of 43 originally recruited
participants dropped out due to physical diseases. We present re-
sults for the 39 participants completing the 12-week study: inter-
vention group (n = 20) and control group (n = 19).
The study excluded patients on donepezil for less than six months,
those with an MMSE score of 19 and under or an MMSE score
25 or more and not fulfilling the inclusion criteria, and those with
primary symptoms related to speech and impaired executive func-
tion, without findings characteristic of Alzheimer’s disease. Partic-
ipants were recruited from the outpatient clinic of theDepartment
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of Psychiatry or Memory Clinic, National Center for Geriatrics
and Gerontology.
Rusted 2006: The study included 31 female participants with an
average age of 84.05 years (range 74 to92) and14male participants
with an average age of 80.33 years (range 67 to 92). Twenty-four of
45 originally-recruited participants dropped out due to death, ill
health, changes in care provision, transport or changes in residence
beyond the participants’ control. Results are presented for the 21
participants completing the 40-week study: intervention group (n
= 9) and control group (n = 12).
In this study different types of dementia diagnosis amongst partic-
ipants were as follows: Alzheimer type (n = 18; 11 women), multi-
infarct dementia (n = 19; 13 women), unspecified dementia (n =
8; 7 females). Different severities of dementia diagnosis amongst
participants were as follows: mild (n = 4), moderate (n = 8), se-
vere (n = 33). At baseline there was an imbalance in depressive
symptomatology, with higher mean CSDD scores in the art ther-
apy group compared with the activity group (F(1,19) = 8.65, P <
0.01). The study excluded people with psychiatric co-morbidities.
Participants were recruited from those attending at day care and
care-home residents.
(3) Length and duration of sessions and nature of
activities
Hattori 2011: Groups of approximately five participants per ses-
sion met for weekly 45-minute sessions, for 12 weeks. The art
therapy intervention involved a combination of several techniques.
The main task was to colour with pastel crayons or water-based
paint pre-prepared abstract patterns. Additional tasks were to
colour line drawings of familiar objects such as flowers, children
and fish or draw pictures based on memories or favourite seasons.
The intervention was delivered by an industrial designer and artist
and three speech therapists. Participants were also instructed to
carry out tasks within their capability for approximately 15 min-
utes daily. In the control group, the task involved performing sim-
ple calculations (additions and multiplications of 1- and 2-digit
numbers). In both groups, participants were accompanied by their
family members.
Rusted 2006: Groups of up to six participants met for weekly one-
hour sessions for 40 weeks. The art therapy intervention involved
a group interactive, psychodynamic approach with a variety of
art materials presented for use. The intervention was delivered by
an art therapist or occupational therapist and an assistant, who
had attended induction meetings where the research protocol was
outlined and handbooks on this were provided. Art therapists had
supervision sessionswith the senior art therapist at least fortnightly.
Assistants worked under the guidance of the art therapists and had
supervision with the psychologist regularly. In the control group, a
selection of recreational activities were used, excluding any formal
occupational therapy methods or any form of art and craft work.
(4) Outcome measures
Hattori 2011: MMSE. Increase in score represents improvement.
Wechsler Memory Scale-Revised (WMS-R) sub-scale evaluating
logical memory (WMS-log). Increase in score means improve-
ment. Geriatric Depression Scale (GDS). Reduction in score
means improvement. Apathy Scale (Japanese version). Reduc-
tion in score means improvement. Physical Component Sum-
mary (PCS-8). Increase in score means improvement. Mental
Component Summary (MCS-8). Increase in score represents im-
provement. Dementia Behaviour Disturbance Scale (DBD). Re-
duction in score means improvement. Barthel Index. Increase
in score means improvement. Zarit Caregiver Burden Interview
(CBI). Reduction in score means improvement. Measurements
were recorded at baseline and at 12 weeks.
Rusted 2006: Cornell Scale for Depression in Dementia (CSDD).
Reduction in score represents improvement. The Multi Observa-
tional Scale for the Elderly (MOSES). Reduction in score means
improvement. MMSE. Increase in score means improvement.
Rivermead Behavioural Memory Test (RBMT) sub-test to assess
short-term memory (RBM-STM). Reduction in score means im-
provement. Cornell Scale for Depression in Dementia (CSDD).
Reduction in score represents improvement. Tests of Everyday At-
tention (TEA). Benton Fluency Task (BFT). Measurements were
recorded at baseline, 10 weeks, 20 weeks, 40 weeks and at follow-
up (44 weeks and 56 weeks). Within-session measures were also
used. However this review considers only pre- and post-interven-
tion outcome measures.
Risk of bias in included studies
See: Characteristics of included studies for ’Risk of bias’ tables.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table: Art therapy compared with active control group
activity for people with dementia
See: Characteristics of included studies for Summary of findings
for the main comparison.
It was not possible to obtain adequate data to pool in meta-anal-
yses. Neither study defined outcome measures as primary or sec-
ondary endpoints. There were no clear differences between groups
reported for the outcome measures in question. We considered
the quality of the evidence to be ’very low’ using a GRADE rating
(see: Summary of findings for the main comparison). The find-
ings reported should be interpreted with caution in view of the
limitations identified.
Hattori 2011: At 12 weeks, cognition (MMSE) favoured the cal-
culation group compared with the art-therapy group, whereas the
mental component of health-related quality of life (MCS-8 sub-
scale of SF-8) favoured art therapy compared with learning ther-
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apy performing simple calculations. MMSE score improved in the
calculation (control) group, compared with the art-therapy (inter-
vention) group.
Rusted 2006: At 40 weeks, anxious and depressive symptoma-
tology (CSDD and MOSES) increased in the art-therapy group,
compared with the control group, but the art-therapy group were
more depressed at baseline compared with the control group. No
changes were reported in measures of cognition, memory or at-
tention.
We summarised reported effects of interventions from the two
studies included for all prespecified primary and secondary out-
come measures as follows. No confidence intervals were reported.
Primary outcomes
Cognition
Hattori 2011: The control group mean MMSE score increased
compared with the intervention group mean MMSE score which
decreased: intervention (-0.2) versus control (+2.1).
Rusted 2006: No differences between groups were reported for
MMSE, the Rivermead Behavioural Memory Test, Tests of Every-
day Attention and the Benton Fluency Task.
Affect and emotional well-being
Hattori 2011: No differences were reported in Apathy Scale or
GDS when comparing the two groups.
Rusted 2006: The intervention group showed worsening from
baseline in mean CSDD (P < 0.05). The intervention group
showed worsening from baseline in mean MOSES score for ’de-
pressed/anxious mood’ (P < 0.05).
Social functioning and behaviour
Hattori 2011: No difference was reported in DBD when compar-
ing the two groups.
Adverse effects
Rusted 2006: No clear differences were reported in adverse effects
when comparing the groups. The intervention group were more
depressed at baseline, sowere not comparable to the control group.
Secondary outcomes
Death
Hattori 2011: No information was reported.
Rusted 2006: Ten deaths were reported as unrelated to the trial and
no information was reported on how many were in each group.
Quality of life
Hattori 2011: Percentage showing at least 10% improvement from
baseline in MCS-8 was compared between groups by Chi2 test
and favoured the intervention group (P = 0.038, odds ratio 5.54).
No difference was reported in Zarit CBI when comparing the two
whole groups.
Economic outcomes
No economic outcomes were reported.
D I S C U S S I O N
Summary of main results
We found no clear differences between intervention and control
groups, and we rated the quality of the evidence ’very low’ us-
ing a GRADE rating (see: Summary of findings for the main
comparison).
Overall completeness and applicability of
evidence
There is limited information available on the effectiveness of art
therapy. Searching the literature revealed only two relatively small
randomised controlled trials, with results reported for a total of
60 participants, that were suitable for inclusion.
Overall, regarding the nature of the interventions classified here as
art therapy, more detailed descriptions of the interventions could
be provided (this may be difficult to achieve where a standard-
ised prescribed protocol is not used) and consideration of ways
to monitor therapist adherence to the intervention protocol. The
selection of outcome measures appears appropriate, reflecting an
evaluation of change in key domains as well as one study includ-
ing broader outcome measures to evaluate potential impact on
caregivers. However neither study defined primary and secondary
endpoints.
We assessed both studies for the quality of the description of in-
terventions, using the Template for Intervention Description and
Replication (TIDieR) checklist and guide (Hoffmann 2014). This
is summarised in Table 1. A common and recurring theme was the
need for clarity about the underlying theory or rationale or both
for study design decisions.
Quality of the evidence
(See: Summary of findings for the main comparison and
Characteristics of included studies ’Risk of bias’ tables)
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We used the GRADE approach in interpreting findings (
Langendam 2013; Schünemann 2013).
Overall we judged the evidence for our main outcomes to be of
’very low’ quality, using the GRADE approach. There were serious
limitations in the data available on the outcomes of interest. We
judged the studies to be at very serious risk of bias in terms of per-
formance bias and attrition bias. In relation to the findings, there
are important methodological issues to be considered, including
lack of clarity in the method of randomisation, lack of allocation
concealment and blinding (it is unclear in one study whether the
same personnel delivered the art therapy and control interventions
as well as assessing outcome measures), and attrition rates. The
individual outcomes examined would be downgraded as a result.
Potential biases in the review process
We used standard procedures, as specified, to identify all relevant
studies. We tried, in line with our protocol, to ensure that we
found all relevant published and accessible studies, including con-
tacting authors of included and excluded studies. We made deci-
sions about analysis of data based on our assessment of the qual-
ity of the studies and the data available. For both studies, it was
unclear whether re-analysis was possible or appropriate with the
information available.
Agreements and disagreements with other
studies or reviews
Overall, the evidence about the effectiveness of art therapy for
people with dementia remains limited and inconclusive. Existing
studies vary in participant characteristics, length of individual art-
therapy sessions, number of sessions and duration, nature of the
activities defined as art therapy, the nature of the control condition,
and outcome measures.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is insufficient evidence from randomised controlled trials
to draw any reliable conclusions about the efficacy of art therapy
for people with dementia.
Given the popularity of art therapy with therapists and clients, and
in view of its ongoing clinical use, further and better evaluation
should be pursued.
Implications for research
There is a clear need for more RCTs of art therapy for people
with dementia. Future research on art therapy should seek to ad-
dress the methodological limitations identified in existing studies
and should aim to establish any effects directly attributable to art
therapy as a discrete single-modality intervention. More clearly-
defined treatment protocols are required to identify the key ther-
apeutic elements and evaluate effects of different approaches. Fu-
ture research should also seek to evaluate a wider range of out-
comes for patients, caregivers and staff. Any negative effects must
be assessed and reported to identify whether there are any harmful
effects.
There are a number of challenges faced by researchers in con-
ducting RCTs investigating the efficacy of art therapy for people
with dementia. It is important to acknowledge specific challenges
in adapting complex interventions such as art therapy for assess-
ment in RCTs. The Medical Research Council (MRC) frame-
work provides guidance (Craig 2008). Challenges for researchers
include consideration of the variation in art therapy models and
contextual, therapist and participant factors. Pragmatic trials of
complex interventions might involve standardisation of function
rather than form (Patterson 2015). This suggests that when de-
signing pragmatic trials of complex interventions such as art ther-
apy, for the internal and external validity of the test, interventions
are standardised by function with flexibility in form, including
content or delivery of the intervention. For example, it may be
more effective to tailor the delivery of art therapy to the context,
i.e. to the individual and their circumstances, rather than always
using exactly the same art materials and approaches for ’treatment
fidelity’ (Hawe 2008).
The identified limitations in existing studies need to be addressed.
When designing studies, researchers should consider guidance
from theMRCFramework for theDevelopment andEvaluation of
RCTs for Complex Interventions to Improve Health (Craig 2008)
and the TIDieR checklist (Hoffmann 2014). Investigators should
aim to test clearly-defined hypotheses. Research should also ad-
dress cost effectiveness andwider deliverability of the intervention.
Feasibility studies should be conducted to estimate important pa-
rameters including sample size and recruitment factors. Formal
supervision of intervention and control group facilitators might
provide insights into the effects on staff and issues with patient
adherence. The influence of contextual factors on outcomes might
be better understood through process evaluation (Craig 2008).
Study results, including outcome data and recommendations aris-
ing from the findings, should be reported clearly.
Potential treatment effect modifiers identified in the two studies
included in this review include experience and expertise of the art
therapist, group size and composition, and environmental setting.
This is based on factors suggested to be important in mechanisms
of art therapy, which include the therapeutic relationship estab-
lished with the therapist, the group setting, social interactions and
relationships between group members, and perceptions of the en-
vironment. The art-therapy intervention was delivered by individ-
uals from a wide range of backgrounds with varying levels of expe-
rience and expertise. The group setting varied, with carers being
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present in one study. The environment differed between the two
studies (community setting versus hospital setting). We identified
a further potential treatment effect modifier as the substantial het-
erogeneity in type and severity of dementia.
Future systematic reviews should incorporate subgroup analyses
where possible. These might cover evaluating art therapy for peo-
ple with dementia of different forms and severities, group versus
individual therapy, therapy in the community versus in institu-
tional care, differences between self-reported and observer-rated
outcomes, and differences between cluster-randomised trials and
non-cluster-randomised trials. It may be difficult to focus the pop-
ulation of interest (in terms of clinical profile) unless there are
more high-quality RCTs. The PICO mnemonic (population, in-
tervention, comparison, and outcomes) provides a structured for-
mat to consider each element when formulating a systematic re-
view question. This is applied here for future studies in Table 2.
The above conclusions offer an outline of key challenges and con-
siderations for future research, based on limitations identified in
the existing evidence base.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Hattori 2011
Methods Randomised controlled trial
The study start and end dates were not stated
Participants 43 participants with a formal diagnosis of Alzheimer’s disease, MMSE 20 or higher and
characteristic neuroimaging findings
Attendance at hospital (outpatient clinic) and accompanied by family
Data reported for 39 participants
Interventions Art therapy (experimental) group
Learning therapy performing simple calculations (control) group
Treatment is 45 minute sessions, weekly, for 12 weeks
Outcomes Cognition: Cognitive impairment (MMSE), Logical memory (WMS-R)
Affect and emotional well-being: mood and vitality (GDS and Apathy Scale)
Social functioning and Behaviour: behavioural abnormalities (DBD), sense of burden
of the participants’ families (Barthel Index and Zarit CBI)
Quality of life: SF-8
Notes Study funding sources: comprehensive Research on Aging and Health (as part of Health
and Labor Sciences Research Grants 2006)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Minimisation was reportedly used, which
may be acceptable as a valid parallel or alter-
native approach to stratified randomisation
that aims to ensure balance between groups
across multiple factors, even in small sam-
ples (Altman 2005). However it is arguable
that minimisation allocation lacks proper
randomisation and may only prove valid in
certain experimental contexts. Further de-
tails of the method of allocation used are
not stated in this study, so the judgement
of risk of selection bias remains unclear
Allocation concealment (selection bias) Unclear risk Incompletely defined or insufficient infor-
mation provided by the study authors
Blinding of participants and personnel
(performance bias)
All outcomes
High risk 3 of the 4 therapists delivered both inter-
ventions
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Hattori 2011 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated who carried out the assessments
but is likely to be the investigators
Incomplete outcome data (attrition bias)
All outcomes
High risk Dropouts not included in the analysis (4
participants did not complete the study)
Other bias Unclear risk Both groups are compared before and after
but not head-to-head, apart from respon-
ders showing a 10% or more improvement
in individual outcome measures. Numbers
are not stated
Rusted 2006
Methods Randomised controlled trial (parallel, individual)
The study was completed in 2002
Participants 45 people with a formal diagnosis of dementia (diagnosed by consultant psychogeriatri-
cian)
Attendance at day care or residential facility
Data reported for 21 participants
Interventions Art therapy (experimental) group
Activity (control) group
Treatment is weekly 1-hour sessions for 40 weeks
Outcomes Cognition: Cognitive impairment (MMSE), Short term memory (RBMT), Auditory
and visual attention (TEA), Verbal fluency (BFT)
Affect and emotional well-being: depressive symptomatology (CSDD)
All listed primary outcomes: cognition, affect and emotional well-being, social func-
tioning and behaviour: self-care functioning, disorientated behaviour, depressed/anxious
mood, irritable behaviour, sociability and withdrawn behaviour (MOSES)
Notes Study funding sources: PPP (Health) Foundation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Participants were randomly as-
signed... based on participants’ ID num-
bers being drawn by chance” (p521; pp2)
Allocation concealment (selection bias) Unclear risk Incompletely defined or insufficient infor-
mation provided by the study authors
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Rusted 2006 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not reported and the intervention in ques-
tion is difficult to blind participants and
personnel from
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete outcome data (attrition bias)
All outcomes
High risk High dropout rate is not accounted for in
the analysis (24 out of 45 recruited partic-
ipants did not complete the study). Con-
sidering that the sample sizes are small, this
high attrition rate (53.3%) impacts on the
reliability of this study’s results
Other bias High risk The intervention and control groups were
not comparable at baseline - the art therapy
group had a higher mean depression score
(P < 0.01) than the control group
Benton Fluency Task (BFT); Zarit Caregiver Burden Interview (CBI); Cornell Scale for Depression in Dementia (CSDD); Geriatric
Depression Scale (GDS); Mini-Mental State Examination (MMSE);Multi Observational Scale for the Elderly (MOSES); Rivermead
Behavioural Memory Test (RBMT); Tests of Everyday Attention (TEA); Wechsler Memory Scale-Revised (WMS-R)
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Camic 2014 Study did not compare art therapy with standard care or other psychosocial interventions for dementia
Fostinelli 2016 Not a fully-published randomised controlled trial (conference poster abstract)
Han 2010 Intervention was not art therapy - a music therapy and activity programme was used
Jensen 1997 Intervention was not restricted to art therapy - a multisensory intervention combining art, music and movement
was used
Kong 2015 Unable to confirm as a randomised controlled trial based on information available (abstract only)
MacPherson 2009 Intervention was not art therapy - did not involve art-making
NHS 2012 Intervention was not art therapy
17Art therapy for people with dementia (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Odell-Miller 2006 Intervention was not restricted to art therapy - treatment was 1 of 4 arts therapies (music, art, drama, or dance-
movement)
Rusted 2002 Not a fully-published randomised controlled trial (conference abstract)
Rylatt 2012 Not a randomised controlled trial
Safar 2011 Not a randomised controlled trial
Seifert 2003 Not a randomised controlled trial
Stallings 2010 Not a randomised controlled trial
Ullan 2013 Not a randomised controlled trial
Walsh 2011 Not a randomised controlled trial
A D D I T I O N A L T A B L E S
Table 1. TIDieR assessment
Item No Hattori 2011 Rusted 2006
Brief name
1 The term ’art therapy’ is used to describe the intervention. The term ’art therapy’ is used to describe the intervention.
Why
2 More information could be provided regarding the under-
lying rationale for the prescriptive art-making activities de-
signed. Overall, the rationale, theory or goal of the elements
deemed essential to the intervention could be stated more
clearly
The underlying rationale, theory or goal of the elements
deemed essential to the intervention could be stated more
clearly
What
3 Materials: The materials used in delivering the intervention
are clearly described
Materials: The “variety of art materials” used in delivering
the intervention could be described inmore detail to further
define the methodology and aid replicability
4 Procedures: The intervention is reported to have “combined
several techniques” which could be elaborated on. A chosen
“primary task” is identified and described in further detail
Procedures: The procedure used is reported as a “group-
interactive, psychodynamic approach”
Who provided
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5 Each category of intervention facilitator, their expertise and
background are detailed. Their specialty backgrounds and
levels of experience varied. It is unclear whether there was
any specific training or a standardised protocol in terms of
delivering an art therapy intervention
Information is provided regarding each category of inter-
vention facilitator and their expertise. Levels of experience
are not reported. Reference is made to “induction meet-
ings” and “handbooks” outlining the research protocol for
all therapists and assistants
How
6 Modes of delivery of the intervention and group settings (in-
cluding the presence of family accompanying participants)
are clearly described. There could be further reference made
to expert literature or clinical experience or both to support
these decisions
Modes of delivery of the intervention and group settings
are clearly described. There could be further reference to
expert literature or clinical experience or both to support
these decisions
Where
7 The location for the intervention is described as hospital
outpatient clinic setting. There could be further discussion
about the choice and potential implications of this
The location for the intervention is described as day care
setting. The context of delivery of this type of intervention
may be important, including environmental factors in fa-
cilitating group interaction and psychotherapy approaches.
Therefore further discussion about the choice of location
could be included
When and How Much
8 The total period of time and the number, frequency and
duration of intervention sessions are clearly reported. Fur-
ther information regarding the underlying rationale would
be valuable
The total period of time and the number, frequency and
duration of intervention sessions are clearly reported. Fur-
ther information regarding the underlying rationale would
be valuable
Tailoring
9 In addition to scheduled group sessions of fixed duration,
the interventionwas tailored to individual ability in somuch
as participants were, “instructed to carry out tasks within
their capability for approximately 15 minutes daily”. The
rationale for reported parameters as theoretically acceptable
or appropriate would be valuable
-
Modifications
10 - -
How well
11 - Some facilitators had regular supervision sessionswhilst oth-
ers did not. The rationale for regular supervision being of-
fered could be more clearly stated. For example, this might
be to replicate real-life practices or as a possible method of
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assessing, maintaining or improving fidelity
12 - The rationale for supervision and implications of discrep-
ancy in attendance, could be extended beyond measuring
outcomes. For example, this might include assessment of
adherence and incorporating strategies to maintain or im-
prove fidelity
Table 2. PICO criteria - considerations for future research
PICO Research question components
P: Population of interest or problem to be addressed Participants with specified type and severity of dementia
I: Intervention to be considered Art therapy as defined by the British Association of Art Therapists as a
gold standard
C: Comparison or control intervention Non-active control: no treatment, usual care, waiting list
Active control group: attention placebo or other form of psychological
intervention for dementia
O: Outcome of interest Primary outcomes
Cognition - attention/orientation,memory, fluency, language, visuospatial
perception
Affect and emotional well-being
Social functioning
Behaviour
Neuroimaging
Secondary outcomes
Adverse effects
Death
Quality of life
Economic outcomes
Carer outcomes
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A P P E N D I C E S
Appendix 1. Sources searched and search strategies
Source Search strategy Hits retrieved
1. ALOIS (www.medicine.ox.ac.uk/alois)
[Latest search 04 November 2016]
art, artistic, artist, artwork, draw, drawing,
paint, painting, sketch, sketching, doodle
May 2014: 5
Mar 2015: 0
Jan 2016: 0
Nov 2016: 1
Oct 2017: 1
2. MEDLINE In-process and other non-
indexed citations and MEDLINE 1946-
present (Ovid SP)
[Latest search 04 November 2016]
1. exp Dementia/
2. Delirium/
3. Wernicke Encephalopathy/
4. Delirium, Dementia, Amnestic, Cogni-
tive Disorders/
5. dement*.mp.
6. alzheimer*.mp.
7. (lewy* adj2 bod*).mp.
8. deliri*.mp.
9. (chronic adj2 cerebrovascular).mp.
10. (“organic brain disease” or “organic
brain syndrome”).mp
11. (“normal pressure hydrocephalus” and
“shunt*”).mp.
12. “benign senescent forgetfulness”.mp.
13. (cerebr* adj2 deteriorat*).mp.
14. (cerebral* adj2 insufficient*).mp.
15. (pick* adj2 disease).mp.
16. (creutzfeldt or jcd or cjd).mp.
17. huntington*.mp.
18. binswanger*.mp.
19. korsako*.mp.
20. or/1-19
21. Art Therapy/
22. art.ti,ab.
23. draw.ti,ab.
24. (artist or artistic).ti,ab.
25. artwork.ti,ab.
26. (drawing* or sketching or sketches or
paint*).ti,ab.
27. (etch* or doodle* or “still life” or trac-
ing).ti,ab.
28. or/21-27
29. 20 and 28
30. randomized controlled trial.pt.
31. controlled clinical trial.pt.
32. random*.ab.
May 2014: 25
Mar 2015: 31
Jan 2016: 41
Nov 2016: 45
Oct 2017: 95
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33. placebo.ab.
34. trial.ab.
35. groups.ab.
36. or/30-35
37. (animals not (humans and animals)).
sh.
38. 36 not 37
39. 29 and 38
3. EMBASE
1974-January 14 2016 (Ovid SP)
[Latest search 04 November 2016]
1. exp dementia/
2. Lewy body/
3. delirium/
4. Wernicke encephalopathy/
5. cognitive defect/
6. dement*.mp.
7. alzheimer*.mp.
8. (lewy* adj2 bod*).mp.
9. deliri*.mp.
10. (chronic adj2 cerebrovascular).mp.
11. (“organic brain disease” or “organic
brain syndrome”).mp
12. “supranuclear palsy”.mp.
13. (“normal pressure hydrocephalus” and
“shunt*”).mp.
14. “benign senescent forgetfulness”.mp.
15. (cerebr* adj2 deteriorat*).mp.
16. (cerebral* adj2 insufficient*).mp.
17. (pick* adj2 disease).mp.
18. (creutzfeldt or jcd or cjd).mp.
19. huntington*.mp.
20. binswanger*.mp.
21. korsako*.mp.
22. CADASIL.mp.
23. or/1-22
24. exp *art therapy/
25. art.ti,ab.
26. draw.ti,ab.
27. (artist or artistic).ti,ab.
28. artwork.ti,ab.
29. (drawing* or sketching or sketches or
paint*).ti,ab.
30. (etch* or doodle* or “still life” or trac-
ing).ti,ab.
31. or/24-30
32. 23 and 31
33. randomized controlled trial/
34. controlled clinical trial/
35. randomly.ab.
36. placebo.ab.
May 2014: 21
Mar 2015: 20
Jan 2016: 45
Nov 2016: 45
Oct 2017: 111
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37. trial.ab.
38. “single-blind*”.ti,ab.
39. “double-blind*”.ti,ab.
40. or/33-39
41. 32 and 40
4. PSYCINFO
1806-January week 2 2016 (Ovid SP)
[Latest search 04 November 2016]
1. exp Dementia/
2. exp Delirium/
3. exp Huntingtons Disease/
4. exp Kluver Bucy Syndrome/
5. exp Wernickes Syndrome/
6. exp Cognitive Impairment/
7. dement*.mp.
8. alzheimer*.mp.
9. (lewy* adj2 bod*).mp.
10. deliri*.mp.
11. (chronic adj2 cerebrovascular).mp.
12. (“organic brain disease” or “organic
brain syndrome”).mp
13. “supranuclear palsy”.mp.
14. (“normal pressure hydrocephalus” and
“shunt*”).mp.
15. “benign senescent forgetfulness”.mp.
16. (cerebr* adj2 deteriorat*).mp.
17. (cerebral* adj2 insufficient*).mp.
18. (pick* adj2 disease).mp.
19. (creutzfeldt or jcd or cjd).mp.
20. huntington*.mp.
21. binswanger*.mp.
22. korsako*.mp.
23. (“parkinson* disease dementia” or PDD
or “parkinson* dementia”).mp
24. or/1-23
25. exp Art Therapy/
26. art.ti,ab.
27. draw.ti,ab.
28. (artist or artistic).ti,ab.
29. artwork.ti,ab.
30. (drawing* or sketching or sketches or
paint*).ti,ab.
31. (etch* or doodle* or “still life” or trac-
ing).ti,ab.
32. or/25-31
33. 24 and 32
34. trial.ab.
35. “single-blind*”.ti,ab.
36. randomly.ab.
37. “double-blind*”.ti,ab.
38. exp Clinical Trials/
May 2014: 4
Mar 2015: 5
Jan 2016: 5
Nov 2016: 7
Oct 2017: 8
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39. rct.ti,ab.
40. or/34-39
41. 33 and 40
42. 2014*.up.
43. 41 and 42
5. CINAHL (EBSCOhost)
[Latest search 04 November 2016]
S1 (MH “Dementia+”)
S2 (MH “Delirium”) or (MH “Delir-
ium, Dementia, Amnestic, Cognitive Dis-
orders”)
S3 (MH “Wernicke’s Encephalopathy”)
S4 TX dement*
S5 TX alzheimer*
S6 TX lewy* N2 bod*
S7 TX deliri*
S8 TX chronic N2 cerebrovascular
S9 TX “organic brain disease” or “organic
brain syndrome”
S10 TX “normal pressure hydrocephalus”
and “shunt*”
S11 TX “benign senescent forgetfulness”
S12 TX cerebr* N2 deteriorat*
S13 TX cerebral* N2 insufficient*
S14 TX pick* N2 disease
S15 TX creutzfeldt or jcd or cjd
S16 TX huntington*
S17 TX binswanger*
S18 TX korsako*
S19 S1 or S2 or S3 or S4 or S5 or S6 or S7
or S8 or S9 or S10 or S11 or S12 or S13 or
S14 or S15 or S16 or S17 or S18
S20 (MH “Art Therapy”)
S21 TX “art* therap*”
S22 AB art
S23 AB draw
S24 AB artist or artistic
S25 AB artwork
S26 TX drawing* OR sketching OR
sketches OR paint*
S27 TX etch* OR doodle* OR “still life”
OR tracing
S28 S20ORS21OR S22ORS23OR S24
OR S25 OR S26 OR S27
S29 S19 AND S28
S30 (MH “Clinical Trials”)
S31 TX trial
S32 TX “single-blind*”
S33 TX “double-blind*”
S34 TX “treatment as usual”
May 2014: 5
Mar 2015: 0
Jan 2016: 5
Nov 2016: 10
Oct 2017: 44
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S35 TX randomly
S36 S30ORS31OR S32ORS33OR S34
OR S35
S37 S29 AND S36
6. ISI Web of Science Core Collection
[includes: Web of Science (1945-present)
; BIOSIS Previews (1926-present); MED-
LINE (1950-present); Journal CitationRe-
ports]; BIOSIS Previews
[Latest search 04 November 2016]
TOPIC: (dement* OR alzheimer* OR
“vascular cognitive impairment” OR “lew*
bod*” OR CADASIL OR “cognit* im-
pair*”) AND TOPIC: (“art therapy” OR
drawing OR sketching OR doodling OR
painting OR artist OR “still life” OR “art
class” OR “pen and ink”) AND TOPIC:
(randomlyORplaceboORgroupsOR trial
ORRCTOR randomized OR randomised
OR “double-blind*” OR “single-blind*”
OR CCT OR “cross-over” OR crossover)
Search language=English
May 2014: 143
Mar 2015: 98
Jan 2016: 63
Nov 2016: 81
Oct 2017: 222
7. LILACS (BIREME)
[Latest search 04 November 2016]
“art therapy” AND dement$ May 2014: 0
Mar 2015: 0
Jan 2016: 0
Nov 2016: 0
Oct 2017: 0
8. CENTRAL (via CRSO)
[Latest search 04 November 2016]
#1MESHDESCRIPTOR art therapy EX-
PLODE ALL TREES
#2 (artist OR artistic):TI,AB,KY
#3 artwork:TI,AB,KY
#4 (drawing* OR sketching OR sketches
OR paint*):TI,AB,KY
#5 (etch* OR doodle* OR “still life” OR
tracing):TI,AB,KY
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 dementia:MH
#8 MESH DESCRIPTOR Dementia EX-
PLODE ALL TREES
#9 dement*:TI,AB,KY
#10 alzheimer*:TI,AB,KY
#11 #7 OR #8 OR #9 OR #10
#12 #6 AND #11
May 2014: 12
Mar 2015: 5
Jan 2016: 7
Nov 2016: 15
Oct 2017: 42
9. Clinicaltrials.gov (
www.clinicaltrials.gov)
[Latest search 04 November 2016]
(dementia OR alzheimers OR cognition
OR cognitive) AND (art OR paint OR
draw OR sketch)
Filter by Interventional Studies
May 2014: 36
Mar 2015: 0
Jan 2016: 0
Nov 2016: 0
Oct 2017: 16
10. ICTRP Search Portal (http:/
/apps.who.int/trialsearch) [includes: Aus-
tralian New Zealand Clinical Trials Reg-
(dementia OR alzheimers) AND (art OR
paint OR draw OR sketch)
Recruitment status: All
May 2014: 21
Mar 2015: 3
Jan 2016: 0
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istry; ClinicalTrilas.gov; ISRCTN;Chinese
Clinical Trial Registry; Clinical Trials Reg-
istry - India; Clinical Research Informa-
tion Service - Republic of Korea; German
Clinical Trials Register; Iranian Registry
of Clinical Trials; Japan Primary Registries
Network; Pan African Clinical Trial Reg-
istry; Sri LankaClinical TrialsRegistry; The
Netherlands National Trial Register]
[Latest search 04 November 2016]
Nov 2016: 0
Oct 2017: 0
TOTAL before de-duplication May 2014: 272
Mar 2015: 162
Jan 2016: 166
Nov 2016: 204
Oct 2017: 539
TOTAL: 1343
TOTAL after de-duplication and first-assessment by information specialists based on
title and abstract
May 2014: 23
Mar 2015: 0
Jan 2016: 15
Nov 2016: 4
Oct 2017: 22
TOTAL: 64
C O N T R I B U T I O N S O F A U T H O R S
SR Deshmukh wrote the initial version of the protocol and review.
JD Holmes and AG Cardno commented on the protocol and review.
JD Holmes acts as the guarantor of the review.
Independently, two review authors assessed all the studies identified through the search strategy for eligibility. This was shared between
the three review authors. Where necessary, we resolved any disagreement through discussion or, if required, by consulting a third party.
For eligible studies, SR Deshmukh and JD Holmes independently extracted and cross-checked outcome data and assessed risks of bias
for included studies using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
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S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• NIHR, UK.
This review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane
Dementia and Cognitive Improvement group. The views and opinions expressed therein are those of the authors and do not
necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The following summarised differences between protocol and review are attributed to limitations in the availability of relevant studies
and data. The protocol included methods for data analysis, but it was not possible to obtain adequate data to pool in meta-analyses.
We planned to separate participant data into prespecified subgroups listed in the protocol, in order to check for important comparisons
between them, but insufficient data are currently available for this.
The following summarised differences between protocol and review are attributed to changes made to the review to incorporate
new formats and requirements for Cochrane Reviews. We used the GRADE approach in interpreting findings (Langendam 2013;
Schünemann 2013) and created a ’Summary of findings’ table.
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